Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial)-Reference-Cited by-同舟云学术

Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial)

Published:2019-12 Issue:12 Volume:124 Page:1912-1917
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Hanff Thomas C.^ORCID,Kaye David M.,Hayward Christopher S.^ORCID,Post Martijn C.,Malek Filip,Hasenfuβ Gerd,Gustafsson Finn,Burkhoff Daniel^ORCID,Shah Sanjiv J.^ORCID,Litwin Sheldon E.^ORCID,Kahwash Rami,Hummel Scott L.^ORCID,Borlaug Barry A.,Solomon Scott D.,Lam Carolyn S.P.,Komtebedde Jan,Silvestry Frank E.

Funder

National Institutes of Health

American Heart Association

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Heart failure with preserved ejection fraction;Reddy;Curr Probl Cardiol,2016

2. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial;Yusuf;Lancet,2003

3. Irbesartan in patients with heart failure and preserved ejection fraction;Massie;N Engl J Med,2008

4. Spironolactone for heart failure with preserved ejection fraction;Pitt;N Engl J Med,2014

5. Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure;Kaye;J Card Fail,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Late Outcome of a Left-Atrial-to-Coronary-Sinus Shunt;JACC: Case Reports;2023-11

2. Key Phenotypes of Heart Failure with Preserved Ejection Fraction;Cardiology Clinics;2022-11

3. The future of heart failure with preserved ejection fraction;Herz;2022-06-29

4. Efficacy of interatrial shunt devices: an opening window to acute pulmonary hypertensive crisis and chronic pulmonary arterial hypertension;Journal of Thrombosis and Thrombolysis;2022-03-13

5. Device-Based Circulatory Support Therapy for Heart Failure with Preserved Ejection Fraction;Advances in Cardiovascular Technology;2022